Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Completed × Oxycodone × Clear all

Phase

Phase 4 13 Phase 2 5 Phase 3 3 Phase 1 3 Phase NA 1 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 1 Agnosia 1

Interventions

Magnetic Resonance Spectroscopy 22 Metformin 14 pembrolizumab 12 Radiotherapy 11 Biopsy 11 Nivolumab 9 Fluorouracil 9 Cyclophosphamide 9 Radiation 7 Bevacizumab 7 gallium 68 PSMA-11 6 Temozolomide 6 Sirolimus 6 Rituximab 6 Letrozole 6 Etoposide 6 Cisplatin 6 Aspirin 6 Surveys and Questionnaires 5 Oxaliplatin 5 Irinotecan 5 Indocyanine Green 5 Granulocyte Colony-Stimulating Factor 5 Fluorodeoxyglucose F18 5 olaparib 4 aldesleukin 4 Surgical Procedures, Operative 4 Radiosurgery 4 Proflavine 4 Methotrexate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03317730 2021-07-20

RAD 1702

University of Alabama at Birmingham

Phase EARLY_PHASE1 Completed

Agnosia, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡